{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:53Z","timestamp":1772121713113,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vaccine.2024.04.073","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:47:17Z","timestamp":1714751237000},"page":"3621-3629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development"],"prefix":"10.1016","volume":"42","author":[{"given":"Jonas E.","family":"Mertens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6883-2803","authenticated-orcid":false,"given":"Cassandra A.","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martino","family":"Bardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-6452","authenticated-orcid":false,"given":"Doris","family":"Quinkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8517-9147","authenticated-orcid":false,"given":"Mimi M.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ababacar","family":"Diouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-4814","authenticated-orcid":false,"given":"Sarah E.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan E.","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-1357","authenticated-orcid":false,"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-2432","authenticated-orcid":false,"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.073_b0005","series-title":"World malaria report 2023","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.vaccine.2024.04.073_b0010","doi-asserted-by":"crossref","first-page":"e1814","DOI":"10.1371\/journal.pntd.0001814","article-title":"A long neglected world malaria map: Plasmodium vivax endemicity in 2010","volume":"6","author":"Gething","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.04.073_b0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","article-title":"Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite","volume":"9","author":"Mueller","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.073_b0020","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking P. falciparum map","volume":"36","author":"Price","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2024.04.073_b0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"White","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2024.04.073_b0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pt.2016.12.011","article-title":"Theoretical implications of a pre-erythrocytic Plasmodium vivax vaccine for preventing relapses","volume":"33","author":"White","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2024.04.073_b0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM197608052950602","article-title":"The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy","volume":"295","author":"Miller","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.04.073_b0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0092-8674(92)90642-P","article-title":"A reticulocyte-binding protein complex of Plasmodium vivax merozoites","volume":"69","author":"Galinski","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.04.073_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/CMR.00074-12","article-title":"Evidence and implications of mortality associated with acute Plasmodium vivax malaria","volume":"26","author":"Baird","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2024.04.073_b0050","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1475-2875-7-S1-S9","article-title":"Plasmodium vivax: who cares?","volume":"7","author":"Galinski","year":"2008","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2024.04.073_b0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2024.04.073_b0060","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/infdis\/jit394","article-title":"Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers","volume":"208","author":"McCarthy","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.073_b0065","doi-asserted-by":"crossref","first-page":"e152465","DOI":"10.1172\/jci.insight.152465","article-title":"Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly","volume":"6","author":"Minassian","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2024.04.073_b0070","doi-asserted-by":"crossref","first-page":"e93683","DOI":"10.1172\/jci.insight.93683","article-title":"Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2024.04.073_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-018-0083-3","article-title":"Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial","volume":"3","author":"Singh","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.073_b0080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nsmb.2088","article-title":"Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC","volume":"18","author":"Batchelor","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2024.04.073_b0085","doi-asserted-by":"crossref","first-page":"e1003869","DOI":"10.1371\/journal.ppat.1003869","article-title":"Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC","volume":"10","author":"Batchelor","year":"2014","journal-title":"PLoS Pathog"},{"issue":"15","key":"10.1016\/j.vaccine.2024.04.073_b0090","doi-asserted-by":"crossref","first-page":"eadf1782","DOI":"10.1126\/scitranslmed.adf1782","article-title":"Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection","author":"Hou","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2024.04.073_b0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.04.073_b0100","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/s41564-019-0462-1","article-title":"Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody","volume":"4","author":"Rawlinson","year":"2019","journal-title":"Nat Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.04.073_b0105","doi-asserted-by":"crossref","first-page":"e45829","DOI":"10.7554\/eLife.45829","article-title":"Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research","author":"Mohring","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2024.04.073_b0110","first-page":"e3743","article-title":"Multiplication and growth inhibition activity assays for the zoonotic malaria parasite, Plasmodium knowlesi","volume":"10","author":"Mohring","year":"2020","journal-title":"Bio Protoc"},{"key":"10.1016\/j.vaccine.2024.04.073_b0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12936-023-04766-1","article-title":"Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein","volume":"22","author":"Watson","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2024.04.073_b0120","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/hv.19712","article-title":"Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?","volume":"8","author":"Duncan","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.04.073_b0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/14760584.2016.1141680","article-title":"Progress and prospects for blood-stage malaria vaccines","volume":"15","author":"Miura","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.073_b0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12936-023-04591-6","article-title":"Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies","volume":"22","author":"Miura","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2024.04.073_b0135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/CVI.00042-09","article-title":"Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay","volume":"16","author":"Miura","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.04.073_b0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2019.03.020","article-title":"Therapeutic monoclonal antibodies for ebola virus infection derived from vaccinated humans","volume":"27","author":"Rijal","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2024.04.073_b0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.anai.2020.03.018","article-title":"Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race","volume":"125","author":"Harkness","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2024.04.073_b0150","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.5858\/arpa.2019-0519-CP","article-title":"Variability in the laboratory measurement of cytokines: a longitudinal summary of a College of American Pathologists proficiency testing survey","volume":"144","author":"Knight","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2024.04.073_b0155","doi-asserted-by":"crossref","first-page":"B233","DOI":"10.1016\/j.vaccine.2013.02.040","article-title":"Malaria vaccine R&D in the decade of vaccines: breakthroughs, challenges and opportunities","volume":"31","author":"Birkett","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.073_b0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ncomms1265","article-title":"The global distribution of the Duffy blood group","volume":"2","author":"Howes","year":"2011","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:08:53Z","timestamp":1716563333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0264410X24005140"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.073","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.23.576905","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}